In HealthTech, the average enterprise deal takes six to nine months from first contact to signed contract. Most pipeline generation systems, however, are built around much shorter sales cycles.

What works in a typical B2B environment does not always translate to healthcare. Longer buying cycles, broader stakeholder groups, and more rigorous approval processes require a different approach to outreach and pipeline management.

A five-touch sequence over three weeks, rules that remove prospects after a couple of unanswered emails, or targets based on quarterly deal velocity can all be effective elsewhere. In healthcare, they often lead teams to abandon viable opportunities simply because they are progressing at the pace the sector demands.

Our approach starts with a different assumption: a six-to-nine-month sales cycle is not a problem to fix. It is a reality to plan for.

What is healthcare pipeline generation?

Healthcare pipeline generation is the process of identifying, qualifying and nurturing HealthTech buyers through lengthy procurement and evaluation cycles. Enterprise infrastructure and clinical technology purchases can take six to nine months or longer, involving multiple decision-makers, compliance reviews, and integration assessments.

As a result, healthcare pipeline generation differs from general B2B programmes in its cadence, qualification criteria and the amount of active pipeline required to sustain growth.

Why HealthTech procurement doesn’t follow a SaaS timeline

Healthcare buying cycles run long because of structural features that don’t exist, or exist far less, outside the sector. Independent research puts enterprise HealthTech deals at six to twelve months on average, with HIPAA overhead, business associate agreement negotiation and EHR integration reviews accounting for most of the added length. Other industry research puts the figure higher still for complex clinical or infrastructure procurements, with buying committees of eight to twelve stakeholders and cycles stretching to eighteen months.

3 things drive this, and each one changes how a pipeline system needs to be built.

Buying committees are large and cross-functional. A single deal typically pulls in clinical leadership, IT and security, procurement, finance and, increasingly, a compliance or risk officer. Your champion in IT is not the person who signs off on the contract, and the person who signs off rarely joins a call until month four or five.

Compliance and security review sit in the critical path, not at the end of it. HIPAA and HITECH assessments, security questionnaires, and BAA negotiation need to be addressed from the first meeting. Sellers who treat compliance as a late-stage hurdle rather than a first-conversation topic routinely add months to their own cycle.

Integration risk is a central part of the evaluation process. HealthTech buyers need to understand how a new solution will fit alongside existing EHRs, clinical workflows and technology infrastructure, and that assessment typically involves detailed technical validation rather than high-level discussion.

The real stages of a six-month HealthTech deal

An effective healthcare pipeline system reflects how buying decisions are made, rather than relying on a standard MQL-to-SQL process that rarely matches the realities of healthcare procurement.

The first six to eight weeks are usually focused on reaching the right stakeholders and establishing relevance. Buyers are still defining priorities, understanding potential use cases and deciding whether a conversation is worth continuing. At this stage, credibility and sector knowledge tend to matter far more than urgency.

Between months two and four, technical assessment, security reviews and internal discussions often run alongside commercial conversations. This is where broad stakeholder engagement becomes critical. Opportunities that depend on a single internal advocate can lose momentum quickly when priorities shift, which happens frequently in healthcare environments.

From month four onwards, attention typically turns to procurement, legal review and final approvals. For larger infrastructure or clinical technology purchases, this phase can extend well beyond six months. Because progress is naturally slower here, organisations need enough opportunities advancing through earlier stages to maintain a healthy pipeline and reliable forecasts.

What breaks when you run a 60-day system against a six-to-nine-month cycle

3 failure patterns show up again when a generic B2B pipeline motion gets applied to HealthTech.

Pipeline gets under-built. If your SDR team is resourced to fill a 60-day funnel, you will run out of an active pipeline the moment your first cohort of deals moves into month three. Healthcare pipeline generation demands a higher volume of concurrent opportunities in motion simply to keep the pipeline full at every stage.

Good opportunities get disqualified too early. A rule that says stop chasing after two unanswered touches makes sense in a fast-moving SaaS motion. In HealthTech, silence in week three from a compliance officer who is mid-audit is not disinterestinging and treating it as such throws away opportunities that would have converted with a longer, better-paced nurture sequence.

Forecasting becomes fiction. When reps report pipeline against a 60-day expectation, deals that are genuinely on track start to look stuck by month two, and sales leadership loses trust in the numbers. Building the forecast around the true cycle length, rather than an aspirational one, is what makes the pipeline report useful again.

Building a pipeline system for the actual cycle

A pipeline system engineered for a six-to-nine-month HealthTech cycle looks different at every layer.

In HealthTech, qualification is less about urgency and more about fit, stakeholder alignment and procurement readiness. A qualified opportunity is one where you can identify the buying committee, understand the likely compliance pathway, and see a realistic route to budget approval.

Cadence has to stretch and vary by stage. Early-stage nurture should be spaced in weeks rather than days, and should carry genuinely useful, compliance-aware content rather than another check-in. Mid-stage multi-threading should actively work to bring in the compliance, security and finance stakeholders who join later, rather than waiting for the champion to introduce them.

Healthcare buyers often evaluate vendors as much as product capability. Case studies, security documentation, HIPAA information, and integration details should be readily available, allowing compliance and clinical stakeholders to assess a solution without unnecessary delays.

The same principle applies to pipeline planning. Longer sales cycles require a broader base of opportunities at the top of the funnel, creating a consistent flow of deals through procurement and approval stages rather than relying on a handful of late-stage opportunities to hit quarterly targets.

How The Point Company builds healthcare pipeline generation systems

Rather than importing a generic outbound cadence and hoping it survives contact with a six-month procurement process, we build qualification frameworks, cadences and content around the buying committee healthcare deals involve, and the compliance questions they raise.

That means outreach paced to the real stages of a healthcare deal, multi-threading built into the campaign from week one rather than added once a deal has already stalled, and sales notes and qualification verdicts from every call that give your sales team an accurate, stage-appropriate view of where a deal really sits.

For a HealthTech vendor selling into a market where the average deal takes six to nine months, that’s the difference between a pipeline report your sales leadership trusts and one that quietly falls apart every quarter.

FAQ

Q: How long does a typical HealthTech sales cycle take?

A: Most enterprise HealthTech deals take between six and nine months from first contact to signed contract, with larger infrastructure, clinical or EHR-adjacent procurements often extending to twelve months or more.

Q: Why do healthcare deals take longer than standard B2B SaaS deals?

A: Healthcare buying committees are larger and more cross-functional, compliance and security review sits inside the critical path rather than at the end, and integration risk against existing clinical systems is tested rather than assumed.

Q: How much pipeline volume do I need to hit a healthcare revenue target?

A: Meaningfully, more than a 60-day B2B model would suggest. Because deals take six to nine months on average, you need a larger, continuously replenished pool of opportunities in motion at every stage to keep a predictable number closing each quarter.

Q: What makes a healthcare pipeline generation system different from a general B2B one?

A: Qualification criteria built around committee readiness rather than urgency; cadences paced to match a multi-month cycle rather than a multi-week one, and content that answers compliance and integration questions before they’re asked.

Conclusion

A six-to-nine-month procurement cycle isn’t a flaw in HealthTech sales; it’s the environment you’re selling in, and a pipeline system that ignores it will always under-deliver, however good the outreach copy is. Building for the actual cycle means redefining qualification, repacing cadence, arming reps with the right content at the right stage, and sizing pipeline volume against reality rather than ambition.

The Point Company’s approach reflects how healthcare organisations evaluate and purchase technology, giving clients a pipeline model that remains reliable throughout longer buying and procurement cycles.

If your current pipeline system was built for a shorter cycle than the one you’re actually selling into, that mismatch is very likely where your forecast is breaking down, and it’s worth a conversation before your next quarter starts.